Marble7

Melt&Marble concludes distribution deals

16th November 2026

Submitted by:

Andrew Warmington

Swedish company Melt&Marble has concluded a series of distribution partnerships with regional suppliers. These will make its first commercial bioactive lipid emollient, Marble7, available to the personal care sector. It follows a €7.3 million Series A financing in December 2025 to support the production scale-up and commercialisation of its first ingredients.

The agreements and regions covered are:

  • Eigenmann & Veronelli (Italy, Spain, Poland and Turkey)
  • Bionord (Scandinavia)
  • Cornelius (UK & Ireland)
  • Lavollée (France)
  • Seil (South Korea)
  • Ingredients Plus (Australia & New Zealand) 

“The personal care industry is highly fragmented, and these partnerships give us access to established customer networks, local market knowledge and technical expertise that would take years to build on our own. This is an important step toward bringing our ingredients to market at scale,” said Dr Anastasia Krivoruchko, co-founder and CEO of Melt&Marble. 

Marble7 (INCI: r-Saccharomyces Butter) is a three-in-one bioactive lipid developed using precision fermentation to enable fats and lipids to be produced with targeted structural and performance characteristics. It is said to be rich in omega-7, combining a biomimetic skin lipid profile with structural stability and a melt-on-contact texture, with applications in skin care, hair care and make-up.